Company Valuation: IOL Chemicals and Pharmaceuticals Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2023 2024 2025 2026 2027 2028
Market Cap 1 16,608 21,222 17,964 21,354 56,886 -
Change - 27.78% -15.35% 18.87% 166.39% -
Enterprise Value (EV) 16,608 21,222 17,964 21,354 56,886 56,886
Change - 27.78% -15.35% 18.87% 166.39% 0%
P/E 11.9x 15.8x 17.8x 15.5x 25.8x 20x
PBR 1.1x 1.32x 1.06x 1.19x 2.9x 2.64x
PEG - -4.68x -0.7x 0.4x 0.4x 0.7x
Capitalization / Revenue 0.75x 1x 0.86x 0.92x 2.07x 1.8x
EV / Revenue 0x 0x 0x 0x 2.07x 1.8x
EV / EBITDA 0x 0x 0x 0x 15.6x 12.5x
EV / EBIT 0x 0x 0x 0x 18.2x 14.2x
EV / FCF -0x 0x -0x 0x 20.5x 31.3x
FCF Yield -5.39% 0.78% -1.94% 1.94% 4.88% 3.19%
Dividend per Share 2 0.8 1 4 - - -
Rate of return 1.41% 1.38% 6.54% - - -
EPS 2 4.74 4.58 3.44 4.69 7.5 9.7
Distribution rate 16.9% 21.8% 116% - - -
Net sales 1 22,171 21,328 20,792 23,191 27,424 31,525
EBITDA 1 2,257 2,306 2,023 2,690 3,647 4,540
EBIT 1 2,051 1,677 1,303 1,887 3,123 3,998
Net income 1 1,391 1,344 1,011 1,376 2,198 2,840
Net Debt - - - - - -
Reference price 2 56.58 72.30 61.20 72.75 193.80 193.80
Nbr of stocks (in thousands) 293,528 293,528 293,528 293,528 293,528 -
Announcement Date 4/28/23 5/14/24 5/16/25 5/20/26 - -
1INR in Million2INR
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
25.97x - - - 598M
33.44x12.14x24.6x0.59% 1,047B
29.82x - - 2% 646B
32.61x7.57x15.74x2.68% 451B
19.99x4.75x11.76x2.79% 355B
21.76x5.62x13.93x2.85% 291B
20.88x4.29x12.24x2.06% 252B
27.35x7.07x12.56x2.33% 234B
13.25x4.77x9.95x3.83% 203B
-44.51x6.43x25.11x2.26% 181B
Average 18.05x 6.58x 15.74x 2.38% 365.99B
Weighted average by Cap. 24.24x 8.07x 17.81x 1.97%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


  1. Stock Market
  2. Stocks
  3. IOLCP Stock
  4. Valuation IOL Chemicals and Pharmaceuticals Limited